Article · 29 Aug 2026
Conference abstract
Monitoring multivalent vaccine antigens using a multiplex mesoscale discovery platform assay
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The quantification of antigens and assessment of product potency are important aspects of vaccine testing. The development of in vitro assays that can help reduce time, cost, and animal usage associated with such testing is an increasing priority for vaccine manufacturers. Here, we describe the assessment of a multiplex antigenicity assay applied to TdaP vaccine using the MesoScale Discovery (MSD) platform. The assay is capable of measuring six different antigens simultaneously in the vaccine. Specific antibody pairs for each of the TdaP antigens were selected for the multiplex assay, and antibody cross-reactivity and assay precision was assessed. To investigate the ability of the multiplex assay to detect changes in vaccine antigen profile and stability, samples of a TdaP vaccine were subjected to increasing temperatures during accelerated heat degradation studies (up to 60oC for 12 weeks). The treated samples were then tested using the multiplex MSD antigenicity assay and simultaneously using three animal-based tests: 1) A component pertussis (cP) mouse immunogenicity assay; 2) the USPHS Diphtheria Potency assay, and; 3) the USPHS Tetanus Potency assay. Results confirmed that the multiplex MSD antigenicity assay is stability indicating, as it was able to detect changes in the antigenic profile of the vaccine. The MSD assay showed a decline in measured antigenicity values for most of the TdaP antigens over time at the elevated temperatures. In concordance, the cP mouse immunogenicity test results showed decreasing antibody titers for each of the antigens that displayed a drop in antigenicity, while the USPHS Diphtheria and Tetanus potency assays also showed a decrease and/or loss in potency upon heat degradation. Overall, the results support that the MSD in vitro multiplex antigenicity assay, with further development, could potentially act as a surrogate assay used to measure vaccine potency traditionally assessed using animal assays.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Jason Szeto”
- BylineArticles whose byline prints “Melinda Donovan”
- BylineArticles whose byline prints “Pavel Neogi”
- BylineArticles whose byline prints “Tricia Chen”
- BylineArticles whose byline prints “Bing Li”
- BylineArticles whose byline prints “Natalie Au”
- BylineArticles whose byline prints “Manvi Hasija”
- BylineArticles whose byline prints “Kirsten Strahlendorf”
